Kelley Brant

NPI: 1912641390
Total Payments
$12,508
2024 Payments
$12,203
Companies
6
Transactions
45
Medicare Patients
61
Medicare Billing
$4,239

Payment Breakdown by Category

Consulting$6,980 (55.8%)
Travel$3,590 (28.7%)
Food & Beverage$1,916 (15.3%)
Education$22.52 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $6,980 3 55.8%
Travel and Lodging $3,590 12 28.7%
Food and Beverage $1,916 29 15.3%
Education $22.52 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $7,160 21 $0 (2024)
United Therapeutics Corporation $4,991 19 $0 (2024)
AstraZeneca Pharmaceuticals LP $149.34 2 $0 (2024)
GlaxoSmithKline, LLC. $132.78 1 $0 (2024)
JAZZ PHARMACEUTICALS INC. $58.50 1 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $16.25 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $12,203 40 Boehringer Ingelheim Pharmaceuticals, Inc. ($7,137)
2023 $305.05 5 United Therapeutics Corporation ($223.26)

All Payment Transactions

45 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/19/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $149.57 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
12/16/2024 Bayer Healthcare Pharmaceuticals Inc. Adempas (Drug) Food and Beverage In-kind items and services $16.25 General
Category: Cardio-pulmonary
11/04/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $122.02 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
11/04/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug), AIRSUPRA Education In-kind items and services $22.52 General
Category: Respiratory
10/15/2024 United Therapeutics Corporation TYVASO (Drug) Consulting Fee Cash or cash equivalent $2,730.00 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/08/2024 United Therapeutics Corporation Food and Beverage Cash or cash equivalent $95.73 General
10/08/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $27.64 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/07/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $106.83 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/06/2024 United Therapeutics Corporation Food and Beverage In-kind items and services $102.50 General
09/30/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $25.47 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/27/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $64.93 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/27/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $46.38 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/27/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $24.99 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/27/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $21.20 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/26/2024 United Therapeutics Corporation TYVASO (Drug) Travel and Lodging In-kind items and services $272.46 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
09/26/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $144.43 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
08/27/2024 United Therapeutics Corporation TYVASO (Drug) Travel and Lodging In-kind items and services $786.96 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
07/24/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $46.91 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
07/19/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Consulting Fee Cash or cash equivalent $1,870.00 General
Category: RESPIRATORY
07/19/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Travel and Lodging In-kind items and services $140.00 General
Category: RESPIRATORY
07/19/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $35.00 General
Category: RESPIRATORY
07/02/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Travel and Lodging In-kind items and services $168.14 General
Category: RESPIRATORY
06/21/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Travel and Lodging In-kind items and services $140.34 General
Category: RESPIRATORY
06/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $64.62 General
06/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $27.35 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 61 62 $14,219 $4,239
Total Patients
61
Total Services
62
Medicare Billing
$4,239
Procedure Codes
3

All Medicare Procedures & Services

3 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 37 37 $9,971 $2,946 29.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 11 12 $2,376 $759.00 31.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 13 13 $1,872 $533.32 28.5%

About Kelley Brant

Kelley Brant is a Family healthcare provider based in Murray, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2022. The National Provider Identifier (NPI) number assigned to this provider is 1912641390.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelley Brant has received a total of $12,508 in payments from pharmaceutical and medical device companies, with $12,203 received in 2024. These payments were reported across 45 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($6,980).

As a Medicare-enrolled provider, Brant has provided services to 61 Medicare beneficiaries, totaling 62 services with total Medicare billing of $4,239. Data is available for 1 year (2023–2023), covering 3 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Murray, UT
  • Active Since 04/22/2022
  • Last Updated 07/31/2024
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1912641390

Products in Payments

  • OFEV (Drug) $5,808
  • TYVASO (Drug) $4,667
  • NUCALA (Biological) $132.78
  • AIRSUPRA (Drug) $126.82
  • XYWAV (Drug) $58.50
  • BREZTRI (Drug) $22.52
  • Adempas (Drug) $16.25

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Murray